SAN FRANCISCO, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Vineti, Inc., the leading software and analytics company for cell and gene therapies, today announced that it will be expanding its technology ...

The company also welcomes new board member and industry expert Cyrus K. Mirsaidi in furthering Sanguine's mission to integrate patients into the therapeutic research and development process. Human ...

When Michael Linenberger, MD, retires from Fred Hutchinson Cancer Center at the end of 2022, his legacy will be felt by coworkers, trainees, patients and their families long after he has left the ...

Standardization in the cell and gene therapy industry is not easy. Stakeholders from across the industry must come together to develop, agree on, and adopt a standard because standards must reflect ...